GlassScriptPhysician profile
Benjamin J Ditty
NPI 1215163795
$557,273.33
in general payments reported to CMS, 2019-2025
42 companies · $142K in 2025
The $142K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $41K · 2021: $68K · 2022: $78K · 2023: $76K · 2024: $77K · 2025: $142K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $178K · Consulting Fee: $80K · Travel and Lodging: $32K · Food and Beverage: $5,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $177,617.31 |
| Consulting Fee | $80,117.50 |
| Travel and Lodging | $32,013.09 |
| Food and Beverage | $5,640.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $552,106.87 | 2019-2025 | Other - Miscellaneous, Insignia Acp, Solus Alif |
| Sanara Medtech INC. | $575.51 | 2020-2021 | |
| Carlsmed, INC. | $381.22 | 2022-2024 | Aprevo |
| Orthofix Medical, INC. | $352.35 | 2019-2023 | Spinal-Stim, Spinal-Stim |
| Intrinsic Therapeutics | $340.46 | 2025 | Barricaid Acd (Annular Closure Device) |
| Providence Medical Technology, INC. | $272.76 | 2019-2025 | |
| Medtronic, INC. | $269.17 | 2023 | Clydesdale Ptc Spinal System, Unid_pass |
| Seaspine Orthopedics Corporation | $246.23 | 2020-2022 | |
| Stryker Corporation | $230.44 | 2019-2020 | |
| Nuvasive, INC. | $207.56 | 2019-2020 | |
| Relievant Medsystems, INC. | $193.75 | 2021-2023 | Intracept |
| Abbott Laboratories | $173.86 | 2020-2023 | Proclaim, Eterna |
| Painteq LLC | $167.96 | 2021 | |
| Ge Healthcare | $152.99 | 2023-2025 | |
| Octapharma USA, INC. | $147.31 | 2022-2024 | Panzyga |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Ditty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.